Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of secretin tablet in China. Welcome to wholesale bulk high quality secretin tablet for sale here from our factory. Good service and reasonable price are available.
Secretin Tablet is an oral solid preparation containing natural secretin as the core ingredient and manufactured via a precision formulation process. The tablet adopts film coating technology, which can effectively protect the active secretin ingredient from degradation by gastric acid, ensure the precise release and efficient absorption of the drug after it enters the intestinal tract, and improve bioavailability. Compared with traditional digestive aids, it features stable dosage form and accurate dosage with controllable active ingredient content per tablet. The tablet also exerts a mild onset of action after administration with minor adverse reactions. It is a preferred oral dosage form for the clinical adjuvant treatment of pancreatic hyposecretion, indigestion and other disorders, and can also be used for the daily conditioning of intestinal dysfunction.
Our products Form
Secretin COA
Field of Medical Diagnosis and Treatment
In the field of medical diagnosis and treatment, the core applications of Secretin Tablet revolve around the diagnosis and adjuvant treatment of digestive system diseases, especially those related to the pancreas and stomach. Relying on the physiological characteristics of secretin in regulating the secretion of digestive glands and participating in metabolic regulation, combined with the convenience of the tablet dosage form, it has become an efficient and safe commonly used preparation in clinical diagnosis and treatment. Its specific applications are mainly concentrated in the following three aspects.
Diagnosis of Gastrinoma
Gastrinoma is a neuroendocrine tumor originating from the pancreatic or duodenal mucosa, characterized by excessive gastrin secretion that leads to hypersecretion of gastric acid, and subsequently causes intractable peptic ulcers, diarrhea and other symptoms, posing great challenges to clinical diagnosis. With the specific reaction of its active ingredient, it has become an important tool for the adjuvant diagnosis of this disease and holds extremely high clinical application value.
Compared with the traditional diagnostic method using injectable secretin, it is administered orally without the need for injection by professional medical staff, resulting in higher patient compliance. In addition, the film coating technology of the tablet protects secretin from gastric acid degradation, ensuring that the active ingredient accurately enters the intestinal tract, is absorbed and then exerts its effects. For the diagnosis, after the patient takes a specified dose of the product orally, medical staff collect blood samples at regular intervals to detect changes in serum gastrin levels, monitor gastric acid secretion simultaneously, and observe the intensity and duration of the reaction.
Under normal circumstances, exogenous secretin slightly inhibits gastrin secretion. However, gastrin secretion in patients with gastrinoma is autonomous and not inhibited by exogenous secretin; instead, a specific reaction of a significant increase in gastrin levels occurs. This characteristic can effectively distinguish gastrinoma from other diseases causing excessive gastric acid secretion (such as gastric antral G-cell hyperplasia), providing a reliable laboratory basis for the early diagnosis and differential diagnosis of gastrinoma. It can also be used for the efficacy monitoring of gastrinoma patients after treatment to determine whether the tumor remains or recurs.
Assessment of Pancreatic Function
The pancreas is an important digestive and endocrine organ of the human body, and its exocrine dysfunction is a core pathological feature of various pancreatic diseases (such as chronic pancreatitis, pancreatic cancer, and sequelae of pancreatic trauma). The product can serve as an effective tool for assessing pancreatic exocrine function, and is particularly suitable for real-time functional testing during endoscopic retrograde cholangiopancreatography (ERCP), providing accurate references for disease diagnosis and condition evaluation.
ERCP is an important endoscopic technology for the clinical diagnosis and treatment of pancreaticobiliary diseases. During the procedure, after oral administration of it its active ingredient secretin can specifically stimulate the pancreatic acinar cells and promote the secretion of pancreatic juice (including digestive enzymes such as trypsin, lipase and amylase) and bicarbonate. Medical staff can observe the volume and rate of pancreatic juice secretion through an endoscope, collect pancreatic juice samples at the same time, detect pancreatic enzyme activity and bicarbonate concentration, and then comprehensively evaluate the status of pancreatic exocrine function.
In patients with normal pancreatic function, pancreatic juice secretion increases significantly after oral administration of Secretin Tablet, with pancreatic enzyme activity and bicarbonate concentration within the normal range. In patients with pancreatic insufficiency, such as those with chronic pancreatitis, the reactivity to secretin decreases due to damage to pancreatic acinar cells, resulting in reduced pancreatic juice secretion, decreased pancreatic enzyme activity, insufficient bicarbonate concentration and other manifestations, and the degree of abnormality is positively correlated with the degree of pancreatic damage.
In addition, the product can be used to distinguish the etiology of pancreatic exocrine insufficiency, helping clinicians judge whether it is caused by pathological changes of the pancreas itself or indirectly affected by other diseases (such as biliary obstruction), and providing an important basis for the formulation of subsequent treatment plans.
Field of Scientific Research and Experiments
In the field of scientific research and experiments, the product has emerged as a pivotal tool for investigating hormonal regulatory mechanisms and developing novel therapeutic approaches, thanks to the high purity of its active ingredient, stable dosage form and strong functional specificity. It is widely applied in research projects across basic medicine, clinical medicine and other related fields, providing robust support for the in-depth advancement of medical research. Its specific applications are mainly reflected in the following two aspects.
Investigating Hormonal Regulatory Mechanisms
Secretin Peptide is the first discovered hormone in the human body. As a typical representative of intestinal hormones, it plays a core role in the regulation of the digestive and metabolic systems. As a standardized oral preparation of secretin, Secretin Tablet serves as a stable and reliable experimental material for studying hormonal regulatory mechanisms, and is particularly suitable for exploring the functional mechanisms and signaling pathways of secretin in the digestive and metabolic systems.
In basic medical research, researchers can administer different doses of it orally to experimental animals (such as mice, rats and dogs), observe its effects on the functions of organs including the pancreas, gastrointestinal tract and liver, and detect changes in the secretion of related hormones (e.g., gastrin, cholecystokinin, insulin). This enables the clarification of the specific mechanisms by which secretin regulates pancreatic exocrine secretion, gastrointestinal peristalsis and gastric acid secretion, as well as its interactive relationships with other hormones.
For instance, experiments have revealed that secretin not only stimulates the pancreas to secrete pancreatic juice, but also indirectly modulates gallbladder contraction and bile excretion by regulating the secretion of cholecystokinin, thereby participating in the process of fat digestion and absorption.
Developing Novel Therapeutic Approaches
Based on the physiological effects and functional mechanisms of Secretin Peptide, the product, as its standardized preparation, provides an important pharmaceutical foundation and experimental tool for the development of novel therapies. Leveraging the functional characteristics of its active ingredient, researchers continuously explore its application potential in a variety of diseases such as hormone-dependent disorders and metabolic diseases, and develop more targeted, efficient and safe novel treatment regimens.
In the development of novel therapies for hormone-dependent diseases, the specific regulatory effect of secretin has become a research focus. For example, for diseases associated with abnormal intestinal hormone secretion such as gastrinoma and irritable bowel syndrome, researchers investigate the functional mechanism of secretin in it to explore the correction of intestinal hormonal disorders by regulating the secretion or functional targets of secretin, thereby developing novel targeted therapeutic drugs.
Meanwhile, as an oral dosage form, it is more suitable for long-term medication compared with injectable preparations, offering a new dosage form option and therapeutic idea for the long-term treatment of hormone-dependent diseases.
The manufacturing of Secretin Tablet adheres to the core principles of "preserving active ingredients, ensuring dosage form stability and guaranteeing accurate dosage". Relying on modern pharmaceutical technology, it covers three key links: raw material screening, formulation molding and quality control. The entire process complies with GMP production standards, with strict specifications for each step. The specific manufacturing information is as follows.
Screening and Pretreatment of Core Raw Materials
The screening and pretreatment of high-quality raw materials are the core prerequisite for manufacturing, which directly determine the therapeutic effect of the tablets. The active ingredient is high-purity recombinant human secretin with a purity of over 99%. High-performance liquid chromatography (HPLC) is used to confirm the absence of foreign proteins and degradation products, so as to avoid affecting the drug efficacy or causing adverse reactions.
The excipients selected include fillers, binders and lubricants that meet pharmacopoeial standards-microcrystalline cellulose is used as the filler to ensure the moldability of the tablets; hypromellose serves as the binder to enhance particle viscosity; and magnesium stearate is adopted as the lubricant to reduce friction during tableting. All raw materials shall undergo pretreatment such as pulverization, sieving through 80-100 mesh sieve and drying after entering the factory, with the moisture content controlled at 2-3% to ensure uniform mixing in the subsequent process.
Core Manufacturing Technology and Process
The tablet manufacturing adopts the wet granulation process with full automatic control, and the core process is divided into four steps.
Step 1: Mixing and granulation. The pretreated raw materials and excipients are put into a mixer, mixed at a low speed, and then sprayed with a binder prepared with purified water to form a soft material that "clumps when squeezed by hand and disintegrates when lightly pressed", which is then sieved through a 14-20 mesh sieve to make wet granules.
Step 2: Drying. The wet granules are sent to a fluidized bed dryer, with the air inlet temperature controlled at about 60℃ and the air outlet temperature stably maintained at 40-50℃ until the moisture content meets the standard.
Step 3: Granule sizing and total mixing. The dried granules are sized through a 16-20 mesh sieve, and lubricant is added for mixing for 10-15 minutes to ensure uniform granules.
Step 4: Tableting and coating. A high-speed tablet press is used to make plain tablets, which are then coated with a 20-100 micron protective layer via film coating technology to prevent the active ingredients from being damaged by gastric acid, finally forming the finished tablets.
Quality Control Standards and Testing
Stringent quality control is implemented throughout the manufacturing process, covering the testing of raw materials, intermediate products and finished products. For raw materials, purity and microbial limit shall be tested; for intermediate products, particle fluidity, moisture content and tablet weight variation are subject to testing; for finished products, tests are conducted on appearance, disintegration time limit and active ingredient content, and coating defects are also inspected to ensure no cracking, peeling and other problems.
In addition, stability tests shall be carried out on the finished products to simulate different storage environments and detect the stability of drug efficacy and the integrity of dosage form within the validity period. All tests comply with the national pharmacopoeial standards, and unqualified products are strictly prohibited from leaving the factory, so as to ensure that the quality, therapeutic effect and safety of each batch of the product meet the clinical application requirements.
FAQ
What is the use of secretin tablet?
+
-
Secretin human is a secretin hormone used to stimulate pancreatic or gastric secretions to diagnose exocrine pancreas dysfunction, gastrinoma, and abnormalities in the bile and pancreatic ducts. Human secretin is a gastrointestinal peptide hormone that regulates secretions in the stomach, pancreas, and liver.
What are the benefits of secretin?
+
-
Secretin increases bicarbonate secretion from duodenal Brunner's gland as well; this mechanism buffers the acidity from chyme and reduces secretion of acid by parietal cells. Water homeostasis is crucial in maintaining the balance between water intake and excretion in the body.
Hot Tags: secretin tablet, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale